Login
$XHLD
$0.86 +$0.01 (0.95%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
ASSETS
Current Assets:
Cash and cash equivalents
Restricted cash
Accounts receivables, net
Receivable due from related party
Prepaid expenses and other current assets
Total Current Assets
Non-current Assets:
Advance - non-current - related party
Property and equipment, net
Operating lease right-of-use assets, net
Intangible assets, net
Other assets
Total Non-current Assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Trade accounts payable
Accrued expenses
Other payable and accrued expenses
Deferred revenue
Less: current portion
Short-term loans
Related Party
Total short-term loans
Other liabilities
Related Party
Total other liabilities
Total Current Liabilities
Non-current Liabilities:
Non-current lease liabilities
Total Non-current Liabilities
Total Liabilities
Stockholders’ Equity:
Preferred stock; $0.0001 par value – 1,000,000 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued or outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.0001 par value – 250,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 11,977,443 and 3,977,443 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Equity
Total Liabilities & Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support